Jules Mitchel: Thoughts on Risk-Based Monitoring

Article

Applied Clinical Trials

Jules Mitchel of Target Health discusses risk-based monitoring trends in the clinical trials industry


Jules Mitchel of Target Health discusses, his views on its importance of risk-based monitoring in the clinical trials industry, now that is such a popular topic.

SPOTLIGHT EVENTRisk-Based Monitoring – Part Two In Depth ReviewMarch 13, 2014
Cambridge, MassachusettsDownload BrochureRegister

RELATED
- Increasing Intensity of On-Site Monitoring a Troubling Trend
- Industry Metric Indicates Low ROI with Full Source Document Verification
- Has FDA Guidance on Risk-based Monitoring Impacted SDV Coverage Yet?More in Risk-Based Monitoring

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.